StonvexLoading…
StonvexStonvexStonvexCore line items from AMZN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $181.52B | $716.92B | $503.54B | $323.37B |
Operating Income | $23.85B | $79.97B | $55.00B | $37.58B |
Net Income | $90.80B | $77.67B | $76.48B | $70.62B |
EPS (Diluted) | $2.78 | $7.17 | $5.22 | $3.27 |
Total Assets | $916.63B | $818.04B | $727.92B | $682.17B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $101.82B | $86.81B | $66.92B | $57.74B |
Free Cash Flow OCF − CapEx | $-2.47B | $7.70B | $10.56B | $13.48B |
Shares Outstanding | 10.75B | 10.73B | 10.69B | 10.66B |